Clinical Trial

Changes in Renal Perfusion During Hemodialysis in Patients with End-stage Renal Disease

Study acronym: HD-RPC
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Residual renal function (RRF) characteristically declines after patients with end-stage renal disease (ESRD) initiate dialysis. Although RRF preservation correlates with improved patient\'s quality of life and survival prospects, poor understanding of the pathophysiology underlying RRF decline limits protection strategies.
Trial Details
NCT Number NCT06587997
Lead Sponsor Yuanjun Yang
Conditions End-stage Renal Disease
Enrollment 20 participants
Start Date 2024-09-05
Primary Completion 2026-09-03 (estimated)
Study Completion 2026-09-03 (estimated)
Updated on ClinicalTrials.gov 2024-09-19